This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (222)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Prospective Three-Year Study in Ambulant Patients With Generalized Epileptic Seizures

Lars Lund, MD

Arch Neurol. 1974;31(5):289-294.

Abstract
In 32 ambulant epileptic patients, the plasma levels of diphenylhydantoin were measured gas chromatographically monthly to bimonthly for three years. The mean diphenylhydantoin plasma levels were increased from 6.1 ± 2.9µg/ml during the first year to 11.7 ± 3.3µg/ml during the second and 15.0 ± 2.5µg/ml during the third year. The annual mean number of grand mal seizures per patient decreased from 5.8 to 4.1 and 1.6, respectively.

The optimal diphenylhydantoin plasma levels varied between patients and depended on the severity of the epilepsy. In some cases it was close to or above 20µg/ml. Acute cerebellar side effects were rare and reversible.

The overall data strongly suggest that monitoring of the diphenylhydantoin plasma levels is a valuable aid in the management of patients with generalized epileptic seizures.

Author Affiliations
From the Department of Neurology, Karolinska Hospital, and the Department of Clinical Pharmacology, Huddinge Hospital, Karolinska Institutet, Stockholm.

Footnotes
Accepted for publication Aug 5, 1974.

Reprint requests to Department of Neurology, Huddinge Hospital, S-141 86, Huddinge, Sweden (Dr. Lund).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inappropriate requests for serum anti-epileptic drug levels in hospital practice
Walters et al.
QJM 2004;97:337-341.
ABSTRACT | FULL TEXT  

Pediatric Patients With Undetectable Anticonvulsant Blood Levels: Comparison With Compliant Patients
Snodgrass et al.
J Child Neurol 2001;16:164-168.
ABSTRACT  

Anticonvulsant Blood Levels: Historical Review With a Pediatric Focus
Snodgrass and Parks
J Child Neurol 2000;15:734-746.
ABSTRACT  

Evidence-based Implementation of Free Phenytoin Therapeutic Drug Monitoring
Burt et al.
Clin. Chem. 2000;46:1132-1135.
ABSTRACT | FULL TEXT  

Phenytoin Monitoring in the Intensive Care Unit
Justice
Journal of Pharmacy Practice 1995;8:29-38.
ABSTRACT  

The Influence of Seizure Type on the Efficacy of Plasma Concentrations of Phenytoin, Phenobarbital, and Carbamazepine
Schmidt et al.
Arch Neurol 1986;43:263-265.
ABSTRACT  

Carbamazepine Therapy in Trigeminal Neuralgia: Clinical Effects in Relation to Plasma Concentration
Tomson et al.
Arch Neurol 1980;37:699-703.
ABSTRACT  

Carbamazepine vs Phenytoin: A Controlled Clinical Trial in Focal Motor and Generalized Epilepsy
Kosteljanetz et al.
Arch Neurol 1979;36:22-24.
ABSTRACT  

Chronic Cerebellar Stimulation
Van Woert and Rosenbaum
Arch Neurol 1977;34:58-58.
ABSTRACT  

Interlaboratory Variability in Determination of Plasma Antiepileptic Drug Concentrations
Pippenger et al.
Arch Neurol 1976;33:351-355.
ABSTRACT  

Neurology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
ANN INTERN MED 1976;84:618-623.
ABSTRACT